News

Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI Patent

GIMOTI now holds four listed patents with coverage through 2029SOLANA BEACH, Calif., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma,…

2 years ago

SteraMist Welcomes Sterile Grow as U.S. Distributor for Food Safety and Cannabis

-Partnership Expands TOMI’s Market in Food, Agriculture, and Cannabis Industries -FREDERICK, Md., Nov. 27, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental…

2 years ago

Safety Shot, Inc Hires Securities Litigation Attorney Mark R. Basile, Esq. and The Basile Law Firm P.C. – Dilution Funding and Short and Distort Experts

JUPITER, FLORIDA., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Safety Shot, Inc.(NASDAQ: SHOT) (“SHOT” or the “Company”), first patented beverage on…

2 years ago

Australian Civil Construction Entity, State Road Constructions, Selects Intelligent Fingerprinting Drug Screening System as Workplace Drug Screening Solution

NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ: INBS) (“INBS” or the “Company”), a medical…

2 years ago

KFSH&RC Jeddah Hosts The 10th International Nursing Conference Gathering Renowned Global Experts and Specialists

- Honorary Accreditation of the Nursing Residency Program announced KFSH&RC Jeddah Hosts The 10th International Nursing Conference Gathering Renowned Global…

2 years ago

Outlook Therapeutics® Announces Receipt of Type A Meeting Minutes and Reiterates Regulatory Path Forward for ONS-5010

Resubmission of the ONS-5010 BLA on track for the end of calendar year 2024, pending final agreement on a clinical…

2 years ago

Accolade To Present at Piper Sandler 35th Annual Healthcare Conference

SEATTLE, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced…

2 years ago

Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent

STOUGHTON, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today…

2 years ago

DLH to Announce Fiscal 2023 Fourth Quarter Financial Results

ATLANTA, Nov. 27, 2023 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and…

2 years ago